HCONRES 30
108th Congress
House
Health
Autoimmune diseases
Commemorations
Communication in medicine
Communication in science
Conferences
Congress
Congressional tributes
Economics and Public Finance
Environmental Protection
Environmental research
Environmentally induced diseases
Epidemiology
Federal aid to research
Genetic research
Genetics
Government Operations and Politics
Health education
Medical research
Prescription pricing
Expressing the sense of the Congress regarding scleroderma.
Introduced: February 5, 2003
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 14, 2003
Referred to the Subcommittee on Health.
Feb 6, 2003
Sponsor introductory remarks on measure. (CR E139)
Feb 5, 2003
Referred to the House Committee on Energy and Commerce.
Feb 5, 2003
Introduced in House
Plain-English summary
Calls for: (1) recognition of private organizations and health care providers for promoting awareness of and research on scleroderma; (2) greater awareness of the symptoms of scleroderma and contributions to the fight against it; (3) the Government to promote awareness, to adequately fund scleroderma research projects, and to continue to consider ways to improve the quality of health care services for scleroderma patients; (4) the National Institutes of Health to continue to play a leadership role in the fight against scleroderma; and (5) the Centers for Disease Control and Prevention to give priority to establishing a national epidemiological study to better track and gather information about scleroderma.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2